Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 11, 2024 07:00 ET | Source: Medigene AG

Medigene Presents Latest Data on UniTope & TraCR Technology at PEGS and SITC 2024

Planegg/Martinsried, November 11, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor...
October 16, 2024 05:30 ET | Source: Medigene AG

Medigene to Present at Upcoming Scientific Conferences

Planegg/Martinsried, October 16, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor...
May 13, 2024 05:30 ET | Source: Hummingbird Bioscience

Hummingbird Bioscience Presents New Preclinical Data Highlighting Next-Generation Antibody-Drug Conjugate Capabilities at PEGS Boston 2024

Hummingbird Bioscience will present next-generation antibody-drug conjugate capabilities at PEGS Boston 2024 for the first time.
May 07, 2024 10:30 ET | Source: Syntekabio USA Inc.

Syntekabio to Showcase Biologics Discovery Platform at PEGS Boston

NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- Syntekabio (226330.KQ), a global artificial intelligence (AI) drug discovery pioneer, today announced its participation at the 20th Annual PEGS Boston –...
April 25, 2022 08:00 ET | Source: Vaccinex, Inc.

Vaccinex, Inc. Announces Upcoming Presentation at the PEGS Boston Conference & Expo Highlighting Its ActivMAb® Technology for Complex Membrane Antigen Expression to Enable Drug Discovery

ROCHESTER, N.Y., April 25, 2022 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and...
April 11, 2012 09:00 ET | Source: Sirona Biochem Corp.

Sirona Biochem to Present Scientific Poster of Inducer Program at 2012 Protein Engineering Summit (PEGS)

VANCOUVER, BRITISH COLUMBIA--(Marketwire - April 11, 2012) - Sirona Biochem Corp. (TSX VENTURE:SBM)(PINKSHEETS:SRBCF)(FRANKFURT:ZSB), announced today its abstract application to present a...